A Ganesan
A Ganesan
Professor of Chemical Biology, University of East Anglia
Verified email at - Homepage
Cited by
Cited by
The impact of natural products upon modern drug discovery
A Ganesan
Current opinion in chemical biology 12 (3), 306-317, 2008
Natural products and combinatorial chemistry: back to the future
JY Ortholand, A Ganesan
Current opinion in chemical biology 8 (3), 271-280, 2004
Identification of a chemical probe for NAADP by virtual screening
E Naylor, A Arredouani, SR Vasudevan, AM Lewis, R Parkesh, A Mizote, ...
Nature chemical biology 5 (4), 220-226, 2009
Thirty years of HDAC inhibitors: 2020 insight and hindsight
TCS Ho, AHY Chan, A Ganesan
Journal of medicinal chemistry 63 (21), 12460-12484, 2020
The timeline of epigenetic drug discovery: from reality to dreams
A Ganesan, PB Arimondo, MG Rots, C Jeronimo, M Berdasco
Clinical epigenetics 11, 1-17, 2019
TPC2 is a novel NAADP-sensitive Ca2+ release channel, operating as a dual sensor of luminal pH and Ca2+
SJ Pitt, TM Funnell, M Sitsapesan, E Venturi, K Rietdorf, M Ruas, ...
Journal of Biological Chemistry 285 (45), 35039-35046, 2010
The N-Acyliminium Pictet−Spengler Condensation as a Multicomponent Combinatorial Reaction on Solid Phase and Its Application to the Synthesis of …
H Wang, A Ganesan
Organic Letters 1 (10), 1647-1649, 1999
Total synthesis of spiruchostatin A, a potent histone deacetylase inhibitor
A Yurek-George, F Habens, M Brimmell, G Packham, A Ganesan
Journal of the American Chemical Society 126 (4), 1030-1031, 2004
Strategies for the dynamic integration of combinatorial synthesis and screening
A Ganesan
Angewandte Chemie International Edition 37 (20), 2828-2831, 1998
A biomimetic total synthesis of (−)-spirotryprostatin B and related studies
H Wang, A Ganesan
The Journal of organic chemistry 65 (15), 4685-4693, 2000
Natural products as a hunting ground for combinatorial chemistry
A Ganesan
Current opinion in biotechnology 15 (6), 584-590, 2004
Enantioselective synthesis of tranylcypromine analogues as lysine demethylase (LSD1) inhibitors
H Benelkebir, C Hodgkinson, PJ Duriez, AL Hayden, RA Bulleid, ...
Bioorganic & medicinal chemistry 19 (12), 3709-3716, 2011
Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery
A Ganesan, L Nolan, SJ Crabb, G Packham
Current cancer drug targets 9 (8), 963-981, 2009
Epigenetic polypharmacology: from combination therapy to multitargeted drugs
AR de Lera, A Ganesan
Clinical epigenetics 8, 1-21, 2016
Ionic liquid acceleration of solid-phase Suzuki− Miyaura cross-coupling reactions
JD Revell, A Ganesan
Organic Letters 4 (18), 3071-3073, 2002
Azumamides A–E: Histone Deacetylase Inhibitory Cyclic Tetrapeptides from the Marine Sponge Mycale izuensis
Y Nakao, S Yoshida, S Matsunaga, N Shindoh, Y Terada, K Nagai, ...
Angewandte Chemie International Edition 45 (45), 7553-7557, 2006
Solution-phase synthesis of a β-amino alcohol combinatorial library
BL Chng, A Ganesan
Bioorganic & Medicinal Chemistry Letters 7 (12), 1511-1514, 1997
The first biologically active synthetic analogues of FK228, the depsipeptide histone deacetylase inhibitor
A Yurek-George, ARL Cecil, AHK Mo, S Wen, H Rogers, F Habens, ...
Journal of medicinal chemistry 50 (23), 5720-5726, 2007
Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
L Nolan, PWM Johnson, A Ganesan, G Packham, SJ Crabb
British journal of cancer 99 (5), 689-694, 2008
Total Synthesis of the Fumiquinazoline Alkaloids:  Solution-Phase Studies1
H Wang, A Ganesan
The Journal of Organic Chemistry 65 (4), 1022-1030, 2000
The system can't perform the operation now. Try again later.
Articles 1–20